Skip to content
LexBuild

Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments; Correction

---
identifier: "/us/fr/2018-04774"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2018-04774"
section_name: "Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments; Correction"
positive_law: false
currency: "2018-03-09"
last_updated: "2018-03-09"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2018-04774"
document_type: "notice"
publication_date: "2018-03-09"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "83 FR 10493"
fr_volume: 83
docket_ids:
  - "Docket No. FDA-2018-N-0410"
fr_action: "Notice; establishment of a public docket; request for comments; correction."
---

#  Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments; Correction

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice; establishment of a public docket; request for comments; correction.

**SUMMARY:**

The Food and Drug Administration is correcting a notice entitled “Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments” that appeared in the *Federal Register* of February 22, 2018. The document was published with the incorrect docket number. This document corrects that error.

**FOR FURTHER INFORMATION CONTACT:**

Lisa Granger, Office of Policy and Planning, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3330, Silver Spring, MD 20993-0002, 301-796-9115.

**SUPPLEMENTARY INFORMATION:**

In the *Federal Register* of Thursday, February 22, 2018 (83 FR 7727), in FR Doc. 2018-03603, on page 7727, the following correction is made:

1. On page 7727, in the first column, in the header of the document, the docket number is corrected to read “FDA-2018-N-0410.”

Dated: March 5, 2018.

Leslie Kux,

Associate Commissioner for Policy.